Billionaire investor Cyrus Vandrevala targets his next growth-equity focus into health-forward food following the $500 million-plus sale of Good Culture.
Vandrevala’s move aims at tapping into the rising global demand for clean-label and nutrition-led consumer brands.
Earlier this year, L Catterton paid over $500 million for acquiring Good Culture, part of SEMCAP Food, owned by Vandrevala.
The buyer, a private equity firm backed by the family office of Bernard Arnault, Europe’s richest individual and the chairman of LVMH.
As a high-end cultured dairy company, Good Culture was built on protein density, short ingredient lists and clear supply chains.
Traditionally, Vandrevala has invested in sectors that are underpriced. He was known for focusing on India in the early 2000s, when the country was not included in any global equity indices.
SEMCAP Food backs businesses in which supply-chain control and ingredient quality are central to their models. But that strategy carries real execution risk in terms of maintaining high standards requiring sustained investment in sourcing and logistics, thereby squeezing margins.
With regulators in the US and Europe paying close attention to health claims on food labels, the company has reinforced its focus on relatively stable markets.
SEMCAP Food will therefore remain concentrated in the US and Europe, while also monitoring India as both a future market for its portfolio companies and a source of domestic brands with global potential, sources said.
Replicating the Good Culture outcome will hinge on identifying brands at the right moment, in an early stage when larger funds have not driven valuations out of reach.
Since 2022, competition for growth-stage consumer investments has intensified. Clean‑label food has also shifted from a niche market category to a crowded, closely watched sector.